A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect

[1]  Yunfeng Zhao,et al.  PKM2 inhibitor shikonin suppresses TPA‐induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells , 2014, Molecular carcinogenesis.

[2]  M. Yamazaki,et al.  Microbiota-derived lactate accelerates colon epithelial cell turnover in starvation-refed mice , 2013, Nature Communications.

[3]  Peter G. Smith,et al.  Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  K. Aldape,et al.  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect , 2012, Nature Cell Biology.

[5]  G. Semenza,et al.  Emerging roles of PKM2 in cell metabolism and cancer progression , 2012, Trends in Endocrinology & Metabolism.

[6]  S. Rosen,et al.  Glucose transporters in cancer metabolism , 2012, Current opinion in oncology.

[7]  Christian M. Metallo,et al.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis , 2012, Nature chemical biology.

[8]  T. Yao,et al.  Regulation of gene expression by the ubiquitin-proteasome system. , 2012, Seminars in cell & developmental biology.

[9]  C. Thompson,et al.  Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.

[10]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[11]  Xueliang Gao,et al.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. , 2012, Molecular cell.

[12]  R. Hamanaka,et al.  Targeting glucose metabolism for cancer therapy , 2012, The Journal of experimental medicine.

[13]  A. Maitra,et al.  Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways , 2011, Proceedings of the National Academy of Sciences.

[14]  P. Walter,et al.  The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.

[15]  Franziska Hirschhaeuser,et al.  Lactate: a metabolic key player in cancer. , 2011, Cancer research.

[16]  K. Aldape,et al.  Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation , 2011, Nature.

[17]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[18]  Y. Wang,et al.  Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2 , 2011, Oncogene.

[19]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[20]  J. Olzmann,et al.  Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant α-1 antitrypsin from the endoplasmic reticulum , 2011, Nature Structural &Molecular Biology.

[21]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[22]  P. Sutphin,et al.  Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality , 2011, Science Translational Medicine.

[23]  C. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[24]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[25]  Matthew K. Knabel,et al.  Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 , 2011, Cell.

[26]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[27]  J. Albar,et al.  A systematic approach to assess amino acid conversions in SILAC experiments. , 2011, Talanta.

[28]  Ming-Rong Wang,et al.  Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth , 2011, Proceedings of the National Academy of Sciences.

[29]  S. Hanash,et al.  The grand challenge to decipher the cancer proteome , 2010, Nature Reviews Cancer.

[30]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[31]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[32]  Juan Pablo Albar,et al.  Generalized Method for Probability-based Peptide and Protein Identification from Tandem Mass Spectrometry Data and Sequence Database Searching* , 2008, Molecular & Cellular Proteomics.

[33]  Qiuyan Wang,et al.  Inhibition of p97-dependent Protein Degradation by Eeyarestatin I* , 2008, Journal of Biological Chemistry.

[34]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[35]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[36]  Gregor Rothe,et al.  Inhibitory effect of tumor cell-derived lactic acid on human T cells. , 2007, Blood.

[37]  T. Ushijima,et al.  Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. , 2006, Cancer research.

[38]  C. Thompson,et al.  Cancer's sweet tooth. , 2006, Cancer cell.

[39]  Jonathan Weissman,et al.  Molecular Chaperones and Protein Quality Control , 2006, Cell.

[40]  R. Kaufman,et al.  Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation , 2006, The Journal of cell biology.

[41]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[42]  H. Ploegh,et al.  A membrane protein required for dislocation of misfolded proteins from the ER , 2004, Nature.

[43]  T. Rapoport,et al.  A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol , 2004, Nature.

[44]  P. Pandolfi,et al.  Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.

[45]  Xiaohua Shen,et al.  The unfolded protein response in nutrient sensing and differentiation , 2002, Nature Reviews Molecular Cell Biology.

[46]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[47]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[48]  Y. Yu,et al.  Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4. , 2001, Biochemical pharmacology.

[49]  P. Hruz,et al.  Structural analysis of the GLUT1 facilitative glucose transporter (review). , 2001, Molecular membrane biology.

[50]  Mike M. Mueckler Paul W. Hruz.  Structural analysis of the GLUT1 facilitative glucose transporter , 2001 .

[51]  J. Sambrook,et al.  Protein folding in the cell , 1992, Nature.

[52]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[53]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.